Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune dysregulation in the prostates of C57BL/6<sup>Aire-/-</sup> mice mirrors that seen in human benign prostatic hyperplasia.

The Journal of pathology·2026
Same author

DGAT1 Drives Racially Divergent Fibroblast Activation via ERK1/2-Dependent Tumorigenic Signaling in Prostate Cancer.

Cancer research communications·2026
Same author

Peripheral serotonin contributes to testosterone and estradiol induced urinary voiding dysfunction in adult male mice.

American journal of clinical and experimental urology·2026
Same author

A poly(A) isoform-aware single-cell and spatial atlas defines fibroblast niches in the human bladder.

bioRxiv : the preprint server for biology·2025
Same author

Estrogen regulation in the prostate underlies racial disparity in men with benign prostatic hyperplasia.

The Journal of pathology·2025
Same author

DGAT1 as a Racially Divergent Driver of Carcinoma-Associated Fibroblast Activation Drives Tumorigenic Pathways via ERK1/2 Signaling in Prostate Cancer.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Jun 11, 2026

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion
09:18

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion

Published on: April 4, 2025

Modeling stromal-epithelial interactions in disease progression.

Douglas W Strand1, Simon W Hayward

  • 1Division of Urologic Surgery, Vanderbilt University, 1161 21st Avenue S, Nashville, TN 37232, USA. doug.strand@vanderbilt.edu

Discovery Medicine
|July 1, 2010
PubMed
Summary
This summary is machine-generated.

The tumor stroma, crucial for organ function, differs significantly in cancer and can predict recurrence. New models explore stromal-epithelial interactions for therapeutic targets.

More Related Videos

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
07:20

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery

Published on: February 28, 2020

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

Related Experiment Videos

Last Updated: Jun 11, 2026

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion
09:18

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion

Published on: April 4, 2025

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
07:20

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery

Published on: February 28, 2020

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

Area of Science:

  • Oncology
  • Cell Biology
  • Tissue Engineering

Background:

  • The tumor stroma, comprising non-epithelial cells, is vital for organ architecture and function.
  • Reactive stroma surrounding tumors exhibits distinct compositions compared to normal stromal tissue.
  • Stromal phenotype is increasingly recognized for its correlation with and predictive value for disease recurrence.

Purpose of the Study:

  • To review recent advancements in understanding the role of the tumor stroma in cancer progression.
  • To explore how novel models of stromal-epithelial interactions are addressing key questions in the field.
  • To highlight the stroma as a potential therapeutic target in cancer treatment.

Main Methods:

  • Review of current experimental and clinical research on tumor stroma.
  • Analysis of new models simulating stromal-epithelial interactions.
  • Correlation of stromal phenotypes with disease recurrence data.

Main Results:

  • The tumor stroma plays a critical role in cancer progression and malignancy.
  • Stromal composition and phenotype are linked to disease recurrence.
  • The stroma is a viable target for therapeutic interventions.

Conclusions:

  • Significant progress has been made in understanding the tumor stroma's role in cancer.
  • New models are essential for investigating stromal-epithelial interactions.
  • Targeting the tumor stroma offers promising therapeutic strategies for cancer treatment.